Alliances
Takeda Pharmaceutical and a subsidiary of Germany-based Evotec SE forged a long-term research collaboration that will support the Japanese company’s growing number of research stage gene therapy discovery programs.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 6, 2020.
Keele, UK, 31 March 2020: Cobra Biologics, an international CDMO for biologics and pharmaceuticals, announced it is working as part of a consortium led by the Jenner Institute, Oxford University to rapidly develop, scale-up and produce the potential adenoviral vaccine candidate, ChAdOx1 nCov-19, for fast-tracked clinical trials for COVID-19.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 3, 2020.
Shares of Fate Therapeutics were up more than 21% in premarket trading after the company announced a multi-billion dollar deal with Janssen Biotech to develop cell therapies for the treatment of cancer.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 2, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 1, 2020.
Under terms of the agreement, Charles River Laboratories will be able to provide its clients with the use of Deciphex’s flagship product.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 31, 2020.
The two companies will work to develop up to four preclinical compounds discovered by Sitryx for autoimmune diseases.
PRESS RELEASES